We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
M icon
1601
Macy's
M
$6.61B
$77K ﹤0.01%
+2,069
New +$69.3K
MFIC icon
1602
MidCap Financial Investment
MFIC
$800M
$77K ﹤0.01%
4,556
+3,923
+620% +$65.2K
WOR icon
1603
Worthington Enterprises
WOR
$2.83B
$77K ﹤0.01%
2,981
-5,700
-66% -$161K
SBNY
1604
DELISTED
Signature Bank
SBNY
$77K ﹤0.01%
599
-6,341
-91% -$831K
EQBK icon
1605
Equity Bancshares
EQBK
$1.05B
$76K ﹤0.01%
+1,828
New +$73.8K
ITT icon
1606
ITT
ITT
$19.2B
$76K ﹤0.01%
1,449
-7,773
-84% -$406K
MOG.A icon
1607
Moog Inc Class A
MOG.A
$13B
$76K ﹤0.01%
975
+875
+875% +$72.1K
SBS icon
1608
Sabesp
SBS
$18.9B
$76K ﹤0.01%
65,410
+61,893
+1,760% +$97.4K
TRN icon
1609
Trinity Industries
TRN
$2.47B
$76K ﹤0.01%
3,074
-21,179
-87% -$510K
CNCE
1610
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$76K ﹤0.01%
+4,537
New +$88.1K
AYI icon
1611
Acuity Brands
AYI
$10.7B
$75K ﹤0.01%
648
-497
-43% -$60.5K
EHC icon
1612
Encompass Health
EHC
$12.4B
$75K ﹤0.01%
1,386
-3,475
-71% -$174K
ENTG icon
1613
Entegris
ENTG
$21.8B
$75K ﹤0.01%
2,227
-3,849
-63% -$136K
EZPW icon
1614
Ezcorp Inc
EZPW
$1.8B
$75K ﹤0.01%
6,202
+6,155
+13,096% +$80.7K
HCSG icon
1615
Healthcare Services Group
HCSG
$1.51B
$75K ﹤0.01%
1,724
-779
-31% -$30.9K
NPK icon
1616
National Presto Industries
NPK
$987M
$75K ﹤0.01%
601
-461
-43% -$49.8K
PDM
1617
Piedmont Realty Trust
PDM
$1.18B
$75K ﹤0.01%
3,786
+622
+20% +$11.5K
UFI icon
1618
UNIFI
UFI
$128M
$75K ﹤0.01%
+2,372
New +$78.1K
SIFI
1619
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
$75K ﹤0.01%
+5,096
New +$74.7K
ARC
1620
DELISTED
ARC Document Solutions, Inc.
ARC
$75K ﹤0.01%
+42,440
New +$88.5K
SSP icon
1621
E.W. Scripps
SSP
$270M
$74K ﹤0.01%
+5,528
New +$68.8K
VLGEA icon
1622
Village Super Market
VLGEA
$640M
$74K ﹤0.01%
2,538
+2,438
+2,438% +$68.6K
MIME
1623
DELISTED
Mimecast Limited
MIME
$74K ﹤0.01%
1,787
+371
+26% +$15.1K
CPLG
1624
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$74K ﹤0.01%
+2,843
New +$74.8K
JNP
1625
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$74K ﹤0.01%
8,488
+5,692
+204% +$51.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.